Dr. Vince Clinical Research Expands Campus, Invests in People, Infrastructure, and Innovation
ByAinvest
Thursday, Jul 24, 2025 2:06 pm ET1min read
VNCE--
The new building, which will be celebrated with an employee open house, is home to DVCR's finance, human resources, marketing, and volunteer recruitment teams. Strategically located on the existing 75,000-square-foot campus, the building mirrors the headquarters' architectural style, ensuring a seamless and unified environment for employees and visitors alike [1].
"DVCR first opened its doors in late 2022, and in less than three years, we have grown to approximately 250 employees globally," said Dr. Brad Vince, CEO and Chief Medical Officer at DVCR. "That growth—combined with being awarded over 100 clinical trials across Phases I through IV—is a true testament to the dedication of our team and the trust our clients place in us" [1].
The project, which received unanimous approval from the Overland Park Planning Commission in March 2024, broke ground in June 2025 and was completed in under a year, demonstrating DVCR's efficient execution and momentum as a CRO leader [1].
References:
[1] https://www.businesswire.com/news/home/20250724651877/en/Campus-Expansion-Marks-Dr.-Vince-Clinical-Researchs-Investment-in-People-Infrastructure-and-Innovation
Dr. Vince Clinical Research, a fast-growing contract research organization, has opened a new 5,000-square-foot administrative building on its flagship campus in Overland Park, Kansas. The expansion reflects the company's investment in people, infrastructure, and innovation. With approximately 250 employees globally and over 100 clinical trials across Phases I-IV, Dr. Vince Clinical Research continues to grow and attract new clients and talent in the clinical research industry.
Overland Park, Kan.--Dr. Vince Clinical Research (DVCR), a leading contract research organization (CRO), has marked a significant milestone with the official opening of its new 5,000-square-foot administrative building on its flagship campus in Overland Park, Kansas. The expansion underscores DVCR's commitment to operational excellence, people, and infrastructure, as it continues to grow and innovate in the clinical research industry [1].The new building, which will be celebrated with an employee open house, is home to DVCR's finance, human resources, marketing, and volunteer recruitment teams. Strategically located on the existing 75,000-square-foot campus, the building mirrors the headquarters' architectural style, ensuring a seamless and unified environment for employees and visitors alike [1].
"DVCR first opened its doors in late 2022, and in less than three years, we have grown to approximately 250 employees globally," said Dr. Brad Vince, CEO and Chief Medical Officer at DVCR. "That growth—combined with being awarded over 100 clinical trials across Phases I through IV—is a true testament to the dedication of our team and the trust our clients place in us" [1].
The project, which received unanimous approval from the Overland Park Planning Commission in March 2024, broke ground in June 2025 and was completed in under a year, demonstrating DVCR's efficient execution and momentum as a CRO leader [1].
References:
[1] https://www.businesswire.com/news/home/20250724651877/en/Campus-Expansion-Marks-Dr.-Vince-Clinical-Researchs-Investment-in-People-Infrastructure-and-Innovation

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet